Clinical Trials Browser

Leukemia, Myeloid × Methylprednisolone Hemisuccinate × Clear all

NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Phase 3 Terminated

58 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute